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Retinoids (vitamin A compounds) have been shown to profoundly affect cellular
development in vitro (1). The differentiation-inducing activity of these compounds
has been demonstrated with a variety of cell types including human promyelocytic
leukemia (2), neuroblastoma (3), and embryonal carcinoma tumor cells (4). An-
tiproliferative effects of retinoids, uncoupled from cellular differentiation, have also
been extensively reported (1, 5). Recently, retinoic acid (RA)' was identified as an
endogeneous morphogen in chick limb buds (6), suggesting a physiologic role for
retinoids in regulatingcertain "determinational" events during normal development.
RA also displays immunomodulating properties, enhancing both cellular and hu-
moral responses in rodents (7). In studying the effect of retinoic acid on the human
immune response, Sidell and colleagues showed that RA enhanced the mitogenic
responses ofthymocytes to various stimuli (8) and increased the number ofantibody-
producing cells from tonsillar lymphocytes sensitized to sheep erythrocytes (9). In
this latter humoral response, RA acted directly on the B cells to enhance antibody
production, an effect that may relate to the differentiating properties of RA.
Common variable immunodeficiency (CVI) is an acquired syndrome associated
with the inablility to produce a normal quantitative and qualitative antibody re-
sponse (10). Patients have been described who primarily have had enhanced T or
monocyte/macrophage suppressor cell activity (11), loss ofhelper T cell activity (12),
B cell inability to secrete synthesized Ig, or even loss of pre-B cells and B cells in
association with tumors ofthe thymus (13). The majority ofpatients with CVI, how-
ever, have normal or only somewhat reduced levels of B cells (as defined by surface
Ig) which fail to differentiate to secrete Ig in vitro even when provided with the ap-
propriate stimuli for terminal differentiation (14-16). Denis et al. (17) have previ-
ously identified such individuals with apparent intrinsic B cell defects and subse-
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quently established B cell human-human hybridoma lines from these patients, fusing
in vitro-activated B lymphocytes with the parent line WIL2/729 HF (17). These
CVI B cell hybridomas were shown to maintain the functional "defect" of the pa-
tient's B cells: Ig production was substantially lower in comparison to hybridomas
generated with B cells of healthy donors and their ratio of membrane to secretory
form of p chain mRNA (pm/ps) was skewed toward the membrane form, character-
istic of an immature B cell (18).
In the present study we have investigated the effects of RA on hybridomas estab-
lished with B cells from patients with CVI or normal individuals. In assessing a
number ofparameters associatedwith their maturational stageand functionalcapa-
bilities, we demonstrate that RA can selectively induce the differentiation ofthe CVI
hybridomas. These findings have important implications for the use of retinoids to
overcome maturational defects of B cells.
Materials and Methods
Cell Cultures.
￿
Human-human B cell hydridomas were established through fusion ofnormal
or CVI PBL with WIL2/729 HF (17), a cloned hypoxanthine guanine phosphoribocyl trans-
ferase-negative (HGPRT- ) B lymphoblastoid cell line (obtained from Dr. R. Lundak,
University of California at Riverside). The cloned hybrids are free of mycoplasma and have
a modal chromosome number of 92 (tetraploid). Individual patient clones were selected for
their ability to secrete maximum IgM (17). To maintain cell lines, cultures of 0.2-1.0 x 106
cells/ml were passaged twice weekly, resuspended 1:5 in freshRPMI 1640 (M. A. Bioproducts,
Walkersville, MD) supplemented with 10% FCS, 2 mM glutamine, 50 U/ml penicillin, and
50 wg/ml streptomycin (CRPMI).
Treatment ofCells with RA.
￿
All-trans-RA (Sigma Chemical Co., St. Louis, MO) was diluted
in DMSO to a stock concentration oft x 10-2 M, aliquoted, and stored at -70°C. For each
experiment, RA was diluted from the stock solution directly into the growth medium so that
the final DMSO solvent concentration was <0.05% (vol/vol). This solvent concentration had
no effect on any ofthe cell linestested. Unless otherwise indicated, the starting cell concentra-
tion for assessing RA effects was 2 x 104/ml. Cells were counted both by microscopic in-
spection with a hemacytometer and by Coulter Counter (Coulter Electronics, Hialeah, FL).
All handling of the RA was done under subdued light. [3H]Thymidine incorporation was
measured as previously described (8).
Measurement ofIgM in Culture Supernatants.
￿
Cumulative IgM levels in the culture superna-
tants were measured by ELISA as reported (19). To estimate the secretion of IgM during
1 d, we calculated the difference between the levels for 2 successive days.
Surface Phenotype Analysis.
￿
Cell surface binding of fluorescence-conjugated mouse mAbs
directed against B cell surface markers as listed in Table III A was accomplished by incubating
0.5 x 106 cells with saturating concentrations of antibody in 0.1 ml PBS/0.02% sodium azide
for 30 min at 4°C in the dark. After washing the cells, flow cytometry was performed using
an Epics C Flow Cytometer (Coulter Electronics) where at least 5,000 cells were collected
and results were displayed as frequency distribution histograms of log fluorescence. Non-
reacting antibodies were used as negative controls.
Biosynthetic Labeling Immunoprecipitation, and Autoradiography.
￿
3 x 106 cells were washed two
times in leucine-deficient CRPMI (Select-Amine, Gibco Laboratories, Grand Island, NY)
and resuspended in 1 ml. To this was added an equal volume of pH-neutralized, leucine-
deficient CRPMI containing 100 pCi/ml of 4, 5-[3H]L-Leucine (ICN Pharmaceuticals, Inc.,
Cleveland, OH). After incubation for 3 h at 37 °C, the cells were washed one time in a hypo-
tonic salt solution (HSS), 0.01 M NaCl, 0.015 M MgC12, 0.01 Tris-HCI, pH 7.4, then they
were pelleted and resuspended in cold HSS with 0.5% NP-40 (Sigma Chemical Co.). After
20 min at 4°C, the nuclei were pelleted and the lysate was cleared with an additional spin
at 20,000 g for 30 min. For immunoprecipitation, the cleared lysates were incubated for 30SHERR ET AL.
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min with 5 gg/ml of mouse IgG monoclonal against human x chain (Cappel Laboratories,
Malvern, PA) or anti-p chain purified from the ascites of BALB/c females injected with the
hybridoma cell line HB57 (American Type Culture Collection, Rockville, MD). 0.5 ml of
suspended Tachisorb (Calbiochem-Behring Corp., La Jolla, CA) was then added and the
precipitates were collected as described (20). Precipitates were electrophoresed in SDS-10%
PAGE gels (21) which were fixed, soaked in autofluor (National Diagnostics, Inc., Somerville,
NJ), dried, and exposed to photographic film (Kodak X-Omat). Intensity of protein bands
was quantitated by laser densitometry.
RNAAnalyses.
￿
Cytoplasmic RNA was isolated from tissue culture cellsusingthe NP-40
lysis method (22). RNA blotting was carried out essentially as described by Thomas (23)
using the minifold II apparatus from Schleicher & Schuell, Inc., Keene, NH. Glyoxalated
RNA samples (10 pg per slot) were affixed to nitrocellulose paper and hybridized with nick-
translated probes specific for either x, p, or the 3'UT region of 0 actin. After removal of
nonspecifically bound probe byhigh-stringency washes, the filters were exposed to x-ray film,
and the resulting autoradiographs were analyzed by densitometry. The quantity of RNA im-
mobilized for the different samples was standardized by comparison of D actin expression.
The techniques used for the riboprobe Sl nuclease protection assay have been described in
general outline by Quarless and Heinrich (24). Hind III-cleaved pG1us4DNA was used as
a template for the in vitro T7 transcription reaction (see technical bulletin from Promega
Biotech, Madison, WI). The composition of the reaction mixture was such that -1/40 of
the incorporated GTP residues were labeled with 12P The complementary RNA products
of this reaction were electrophoresed over a 4% polyacrylamide, 7 M urea gel using a Tris-
borate running buffer, and full-length probe transcripts (visualized by autoradiography) were
eluted with 0.5 M NH40Ac(pH 7 .5), 10 mM Mg(OAc)2, 0.1% SDS, and then were EtOH
precipitated. The EtOH precipitate was washed once in 70% EtOH at room temperature
and dried under vacuum. The dried probepellet was then resuspended inhybridization buffer
(see technical bulletin from Promega Biotech) to a concentration of 1,000 cpm/pl and stored
at -20'C until being used. Cytoplasmic RNA samples (10 pg) were dried under vacuum at
room temperature, then resuspended in 10 id of the probe solution. The mixture was heat
denatured for 15 min at 85'C, then quickly transferred to a 45°C hybridization bath for
18 h. After hybridization, 10 vol of S1 digestion buffer (30 mM NaOAc, pH 4.5, 100 mM
NaCl, 2 mM ZnS04, 2,500 U/ml Sl nuclease from Sigma Chemical Co.) were added, and
the digestion was allowed to proceed for 1 h at 37'C. The Sl digestion was stopped by the
addition of 3 vol of stopping solution (130 mM Tris HCl, pH 7.5, 17 mM EDTA, 200 mM
NaCl, 1.3 SDS, 100 pg/ml proteinase K[BMB]), followed by a 30-min incubation at 37'C.
The mixtures were then phenol extracted once, combined with 20 pg of carrier tRNA, and
were EtOH precipitated at -20°C for 2 h. The resulting precipitate was washed once with
70°Jo EtOH at room temperature, dried briefly, and resuspended in 809o formamide loading
buffer and electrophoresed on a 4% polyacrylamide, 7 M urea gel usinga Tris-Borate run-
ning buffer. After electrophoresis, the gel was soaked in 10% HAc, 20% McOH for 20 min
in order to leach excess urea, then it was dried and autoradiographed. Densitometric scan-
ning and normalization to a unit probe length allowed for determination of the molar ratio
of secreted to membrane form transcripts (ps/pm).
PlasmidDNAs.
￿
The 0.9 kb genomic Eco RI fragment encompassing Cu4 was ligated into
the Eco RI site of the vector pGEMI to create plasmid pGlus4. The orientation ofthe insert
was chosen such that cleavage of pGlus4 with Hind III, and in vitro transcription from the
plasmid-borne T7 promoter yields a complementary probe that can be used for the Sl anal-
ysis described above. Plasmid pGlus4 was also nick translated and used to probe RNA slot
blots for p . The plasmid pHuKgpt` (25) was nick translated and used as a x-specific probe.
Plasmid pHL 1216 (26) was nick translated and used as a source ofprobe for the 3' untrans-
lated region of the human P-actin gene product.
Cytoplasmic Antibody Staining.
￿
Cells were washed three times in PBS with 0.02% sodium
azide, cytocentrifuged onto glass microscope slides (1-2 x 105 cells/slide), then fixed in ace-
tone for 10 min at room temperature. Staining was accomplished by incubating the slides
with appropriate concentrations of mouse monoclonal (IgGI) anti-human p, anti-human
light chain, or anti-KLH as a negative isotype control (Becton Dickinson & Co., Mountain58
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View, CA) and developingwith a standard ABC kit (Vector Laboratories, Inc., Burlingame,
CA) according to manufacturers' instructions.
Cell CycleAnalysis.
￿
Cells, grown in CRPMI in the absence or presence of RA for varying
times, were washed and resuspended in a hypotonic sodium citrate buffer containing 20 Rg/ml
RNAse (Sigma Chemical Co.), 100 wg/ml propidium iodide (PI) (Calbiochem-Behring Corp.),
and 3 pl/ml Triton-X (staining solution). The samples (106 cells/ml staining solution) were
incubated for %2 to 1 h at 4°C in the dark and submitted to analysis immediately using an
Epics C Cytometer (Coulter Electronics) equipped with an argon laser tuned to 488 nm.
PI emission was collected with an appropriate filter combination by using a 610 LP filter
in front of the red BMT For each sample, at least 10,000 cellswere collected and displayed
as frequency distribution histogramsoflog red fluorescence. The data were stored on diskette
and subsequently analyzed with the Paral program (parametric analysis program), a software
package supplied by Coulter Electronics to compartmentalize the histograms into the com-
ponents of the cell cycle.
Cultures ofFresh B Cells.
￿
Small resting B cells were isolated from the heparinized venous
blood ofCVI patients or normal donors by unit gravity sedimentation oflymphocytes depleted
of SRBC-rosetting cells as described in detail (27). These B cells were cultured in CRPMI
with various combinations of Staphylococcus aureus Cowan strain I (SAC), RA, and T cell-
replacing factors (TRF, a crude 2-d supernatant of PWM-stimulated T cells [27]) at 5 x
105 cells/ml. After 7 d, the cumulative IgM in the culture supernatants were quantitated by
ELISA.
Results
RA Enhances Ig Secretionfrom CVIHybridomas.
￿
We previously derived the hybrid-
omas used in this study by fusing an HGPRT- clone of the lymphoblastoid line,
WIL2/729 HF, with in vitro-activated peripheralblood B cells from individuals with
CVI (17). Hybridomas were also established with B cells from normal individuals
and persons with selective IgA deficiency. These hybridoma clones (all IgM producers),
were notable because they appeared to reflect the functional ability of the activated
B cells of the donor fusion partner and because their phenotypes were different in
comparing normals with CVI patients' hybridomas (17, 18). Clones derived from
CVI B cells secreted lower levels of Ig than normals and the ps/ltm mRNA ratio
was 5-10 times lower than in those derived from normal B cells. In contrast, hybrid-
omas derived from IgA-deficiency patients were similar to normals in their Ig secre-
tion and lts/um ratio (18). Thus, by the criteria of Ig secretion and ps/wm ratio, the
CVI hybridomas presented a less differentiated phenotype than the normal clones
or IgA deficiency clones. This occurred despite the deliberate selection of low IgM-
secreting hybridomas from the pool ofnormal or IgA-deficiency hybridomas for com-
parison with the optimal IgM-secreting CVI hybridoma clones.
We evaluated the effects of RA on Ig production from hybridomas of four CVI
patients, two IgA-deficiency patients, and one normal donor. 2 x 10' cells/ml were
incubated in the absence and presence of 10-6 M RA for 5 d. On day 4 and 5 of
culture, viable cell counts were obtained by trypan blue exclusion and cumulative
IgM levels in the culture supernatant were assessed. IgM secretion on days 4-5 was
then determined on a per cell basis by calculating the difference between the cumu-
lative IgM levels on days 4 and 5 divided by the average number of cells over this
time period. RA enhanced Ig secretion from four of four CVI hybridomas tested,
with no significant enhancement from the normal or IgA-deficient hybridomas (p
< 0.001) (Fig. 1). With all the CVI hybridomas, there was a 30-50% decrease inthe average number of cells counted compared with untreated cultures . Little orno
difference in cell number was observed in the presence or absence of RA with the
normal or IgA-deficient hybridomas . These results were confirmed by measuring
[3H]thymidine incorporation (data not shown) . No differences were seen between
the percent viability in control and RA-treated cultures .
Fig. 2 shows that the increase ofIgMsecretionby RAwasdose dependent; significant
enhancement was first detected at 10-9M while the hybridoma responded equally
well to RA concentrations between 10-5 M and 10-1M RA . At 10-sM RA, IgM
secretion was still at least 80% of the maximal response . As seen in Fig . 3, aug-
mented IgMsecretion could be detected after2 d of culture, with the greatest differen-
tial change occurring at day 3 .
RA Induces De Novo Synthesis ofIgM.
￿
Cells from the CVI hybridoma cloneJK
32 .1, grown in theabsenceor presence ofRA fordifferenttime periods, were pulsed
for 3 h with [3H]leucine and the cells and supernatant were harvested . A portion
of the cell lysates and supernatants were tested for incorporation of label into total
proteinwhilethe remaining lysates andsupernatants were immunoprecipitated, elec-
trophoresed, and analyzed for in vitro p . and light chain synthesis by autoradiog-
raphy . At 72 h, cells treated with 10-6M RA demonstrated a 12-fold increase in w
chain synthesis and a 3-fold increase in x chain production (Fig. 4.) Total protein
SHERR ET AL .
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FIGURE 1 .
￿
Increase inIgM secretion from
RAtreated hybridomas.IgM secretion on
aper cell basison days 4-5 was calculated
as the difference between the cumulative
IgM levels on days 4and5 divided bythe
average number of cells over this time
period. Results show the increased secre-
tion from cells cultured in the presence of
10-6 M RA compared with that from
cells cultured in theabsence ofRA(% con-
trol) . Values ofcontrols are as follows (in
nanograms of IgM/ml/105 cells): A, 8.2 ;
B, 3.8; C, 1.1; D, 0.8 ; E, 14.9; F, 4.9; G, 7.3 .
FIGURE 2 .
￿
Dose-response ofRA effects on IgM secretion from
JK32 .1CVIhybridoma cells. IgM secretion into the supernatant
was assessed on days 4-5 from cultures treated with the indicated
concentrations ofRA .60
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Days after RA treatment
FIGURE 3 .
￿
Time course ofRA enhancement ofIgM
secretion fromJK32 .1 cells. IgM secretion on aper
cell basison each day was calculated as the increase
in cumulative IgM level from the preceding day
divided by the average number of cells overthesame
time period . Results showthe increased secretion for
that 24-h period from cells cultured in the presence
of 10-6MRA compared with that from cells cul-
tured in the absence of RA (% control) .
synthesis usually remained unchanged and never increased more than twofold in
the presence ofRA. We also examined the kinetics of p chain production . Culturing
in RA for as short as 8 h often produced detectable increases in g chain synthesis .
By 24 h, RA-treated cells showed a five fold increase in synthesis of p chain (Table
I), in contrast to the more delayed response (2 d) seen with actual IgM secretion .
To determine if these same events were reflected in the cells' content of It chains,
JK 32.1 cells were cultured for 72 h in the absence or presence of 10-6 M RA and
then stained for cytoplasmic p . In two experiments, -50% ofboth the treated and
untreated cells stained positively for cytoplasmic It while the treated cells showed
a greater than sevenfold increase in secreted IgM . Correspondingly, we observed
a marked qualitative increase in the intensity ofcytoplasmic w staining in the treated
cells, suggesting that the RA had induced a marked increase in the IgM production
from lower level producing cells rather than inducing cells from a non-IgM to an
IgM-producing state in this 72-h time period (Fig . 5) . However, longer treatment
periods with RA (>5 d) often showed an increase in the percentage of positively
staining cells (data not shown) .
FIGURE 4. Increase in It and x chain synthesis in RA-
treatedJK32 .1 cells. Biosynthetically labeled lysates from
3 x 106 cells that had been treated for 72 h with RA (10-6
M) or solvent control were immunoprecipitated with anti-
W (C andD) or anti-x (A andB) andrun on SDS-10% poly-
acrylamide gel at relative dilutions of 1 :1 (B andD) or 1:4
(A and C) as detailed in Materials and Methods . 1251_
labeledhumanIgG (lane G) wasused for orientation ofthe
is chainband . u and is chain levels were quantitated by den-
sitometry from protein bands obtained by immunoprecipi-
tation with anti-It and anti-x antibody, respectively, and
showed a 12-fold increase in W chainanda 3-fold increase in K chain induced byRA. Background bands
showed atwo fold increase, indicating an enhancement byRA oftotal protein synthesis as well as specific
increases in g and is chain production.SHERR ET AL.
TABLE I
Kinetics of RA Enhancement ofR and x Chain Synthesis in,JK32.1 Cells
Cells were cultured for the indicated time period in 10-6 M RA or solvent
control, then pulse-labeled with [3H]leucine for determining p and x chain
levels as described in Materials and Methods.
` Values represent percent increase in the area of p and x chain protein bands
(as determined by densitometric scanning of autoradiograms) from RA-treated
cells relative tocontrol cultures evaluated at the same time. Total TCA precipita-
ble counts did not vary by >25% between RA-treated and control samples
at any of the time points.
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Cell Cycle Analysis.
￿
In Ig-secreting cells, >60% of Ig production occurs late in
G1 (28). In a variety of cell types, RA causes a shift in the distribution of cells within
the cycle, significantly enhancing the percentage of cells in G1 . To assess whether
a shift of CVI hybridoma cells into G1 could account for the enhanced Ig produc-
tion, supernatants from 3-5 d RA-treated and untreatedJK 32.1 cells were assayed
for levels of IgM, while cell nuclei from the same cultures were analyzed for DNA
content by PI staining. The results shown in Fig. 6 from day 3 are representative.
The proportion of cells in G1 changed from 36 to 437o with RA treatment, while
the concentration of IgM in the supernatant increased from 60 to 185 ng/ml. Thus,
although small changes in cell cycle distribution were consistently observed in RA-
treated cultures (up to 15% increase in the number of cells in GI), this fact could
not account for the marked enhancement in Ig secretion caused by RA.
RA Increases Total Ig mRNA andShifts u mRNA Processing to Production of the Secreted
Form. Normal B cellsstimulated to Ig secretion accumulateincreased levels ofheavy
and light chain mRNA, and undergo a dramatic shift in the heavy chain RNA pro-
cessing pathway, leading to the predominant production of secreted u mRNA (29).
We analyzed changes in the steady-state levels of p and x mRNA, and the ratio of
the two forms of the heavy chain transcript (ps/um) in cytoplasmic mRNA isolated
from control and RA-treated JK 32 .1 cells. RNA slot blot hybridization (23) was
used to quantitate the steady-state levels of heavy and light chain mRNAs in cells
treated with increasingconcentrations of RA for 3 d. The results in Table II indicate
that even very low concentrations of RA (10-8 M) enhanced the level of P mRNA
with minimal effects on the level of x mRNA. The highest concentration of RA (10-5
M) led to increased levels of x mRNA (4-fold), and an even more marked increase
in the level of ~t mRNA (15-fold). Thus, RA treatment of the CVI hybridoma clearly
influenced the steady-state levels of both heavy and light chain mRNAs.
To address more specifically the nature of the species contributing to the pool of
heavy chain mRNA, we used a nuclease Sl protection assay to measure the relative
amounts of ps and pm mRNA. The scheme used to distinguish the two species of
heavy chain transcripts and the autoradiographic results from the S1 analysis ofRNAs
derived from control and RA-treatedCVI hybridoma cells are shown in Fig. 7. The
Treatment
period
h
Increased synthesis of.*
x chain
%
p chain
8 ND 1 .8
24 2.3 4.2
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FIGURE 5 .
￿
Immunoperoxidase
staining for cytoplasmic u in
JK32.1 cells . Cells were cultured
for 72 h in the absence (A) or
presence of 10-6 M RA (B) .
Fixed cells were then incu-
bated with amousemonoclonal
(IgG,) anti-human p heavy
chain specific antibody andde-
veloped with acommercialABC
kit according to manufacturer's
instructions . Anonreactingan-
tibody (mouse anti-KLH) was
used as a negative isotype con-
trol (C) .SHERR ET AL .
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FIGURE 6 .
￿
Cell-cycle profiles forJK32 .1 hybridoma
cells . Cells were treated for 3 d in 10-6 M RA or
solvent control, stained with 0 .1 mg/ml propidium
iodide in 0.1% citrate + 0.02 mg/ml RNase on ice,
and analyzed by flow cytometry. Cumulative IgM
secreted into the supernatant ofthe 3-d cultures was
also assessed .
data indicate that cells grown in media alone, or in the presence ofDMSO alone
demonstratea slight preference for theproduction and accumulation ofthe itsmRNA
(approximately two transcripts for every one um transcript) . Treatment of the hy-
bridoma for 3 d with 10 nM RA shifted the us/pm ratio to N8:1 . Increasing the
RA concentration to 10 wM gave a Its/gm ratio of 11:1. Significantly, this same RA
concentration range showed enhancement ofIgM secretion in the culture superna-
tants (see Fig . 2) . Hence, in vitroRA treatment of the CVI hybridoma leads to a
marked alteration in the RNA processing pathway for Ft heavy chain mRNA .
Analysis of Surface Phenotype Changes in RA-treated Cells.
￿
As described above, the
TABLE II
Effects of RA on Steady-State Levels of p and K Chain mRNA
infK 32.1 Hybridoma Cells
Glyoxalated RNA samples (10 gg per slot) were affixed to nitrocellulose paper
and hybridized with nick-translated probes specific for either x, P, or theTUT
region of 0 actin using standard protocols (Materials and Methods) . After
removal of nonspecifically bound probe by high-stringency washes, the filters
were exposed to x-ray film, and the resulting autoradiographs were analyzed
by densitometry . The quantity ofRNA immobilized for the different samples
was standardized by comparison of 9 actin expression . Cells were cultured for
3 d .
Treatment
Increased
is chain
expression of:
w chain
Control 1.0 1.0
DMSO 0.7 1 .3
10-8 M RA 1.5 4.9
10-'M RA 1.7 4.6
10-6 M RA 2.0 6 .1
10-'M RA 3.9 15.464
￿
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FIGURE 7 . Quantitation of
ps/pm ratios in RA-treated
JK32 .1 cells using the riboprobe
Sl assay. Autoradiographic re-
sults from the riboprobe Sl as-
say are shown in the top portion
of the figure . The full-length
probe used for all subsequent
hybridizations is shown in lane
1 . Lanes 2 and 3 are negative
and positivecontrols, respective-
ly. The cell line KR3475 pro-
duces both forms of the heavy
chain transcript, with a strong
predominance of the secreted-
formmRNA. CytoplasmicRNA
from untreated (lane 4) and
DMSO carrier-treated (lane 5)
JK32 .1 cells was used to estab-
lish baseline ratios of the two
mRNA species . Lanes 6-9 show
the effect of a 3-d treatment of
JK32 .1 with various concentra-
tions ofRA. Quantitation ofthe
ps/pm ratio was carried out using densitometry and normalized to unit probe length . The bottom part
of the figure shows the strategy for detecting transcripts corresponding to mRNAs for the secreted and
membrane forms of the g heavy chain. The regions of the probes that are protected from Sl digestion
after mRNA hybridization are pictured .
Surface marker
IL-2-R (CD25)
Leu-8
Leu-17 (CD38)
132 (CD21)
PCA-1
TABLE III
A . B Cell Distribution of Surface Markers
Distribution on B cells
Activated B cells
Resting B cells
Pre-13 and immature B cell, reexpressed on plasma cells
Resting B cells
Plasma cell blast
" Cells were removed from maintenance cultures (2-8 x 105 cell/ml in CRPMI), stained as
described in Materials and Methods, and immediately analyzed in an EPICS C flow cytom-
eter. Results are means of at least three separate tests . Percentages were standardized by
setting cursor to yield 257c positives for the isotype control .
B. Surface Phenotype ofB Cell Hybridomas
Hybridoma
(fusion partner) IL-2-R
Surface
Leu-8
marker (percent
Leu-17
positive)
B-2 PCA-1
WIL2/729 HF <5 57 12 <5 <5
(parent line)
729-PBL (normal) 16 8 14 <5 32
IE 25 15 13 51 28 20
(IgA deficiency)
IE 8.6 20 8 2 47 15
(IgA deficiency)
JK 32 .1 (CVI) <5 72 11 80 <5
RB 18 (CVI) <5 71 21 29 <5
JP 6.12 (CVI) <5 65 <5 62 NDSHERR ET AL .
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FIGURE 8 .
￿
Time course forRA induction ofLeu-17 (CD38) onJK32 .1 cells . Cells were cultured
in 10-6M RA or solvent control and analyzed for expression ofLeu-17 after 8 h (A), 24 h (B),
and 72 h (C) . The mean channel number of Leu-17` cells increased two fold after 72 h,
representing a 10-fold increase in mean fluorescence intensity, while the percent of cells scoring
positive increased from -20% to 98% .
CVI hybridomas appear to maintain an immature character comparable to that of
the peripheral blood B cells of the CVI patients ; the cells secreted low levels ofIgM,
andthe lts/pm ratiowasN2 :1, characteristic ofa restingB cell . TheCVI and normal
hybridomas were screened with five mAbs that define steps in B cell development
(Table III) . Notably, there are instances in which the phenotype ofthe hybridomas
varies significantly from that of the WIL2/729 HF parent line, suggesting that the
surface phenotype ofthe hybridomas reflects, in part, theB cell fusion partner. Fur-
thermore, there are differences between the CVI hybridomas and those obtained
using cells from healthy individuals or persons with selective IgA deficiency. These
differences are most striking for the display of IL-2-R, Leu-8, and PCA-1 (Table
III) . Overall, the CVI hybridomas display a less mature B cell phenotype relative
to their normal counterparts .
SinceRA enhanced Ig production and shifted the its/ltm ratio, we examined the
CVI hybridomas for changes in surface molecule display in response to RA treat-
ment . Expression of Leu-17, a marker that appears late in B cell development on
pre-plasma cells, increased both in percentage and intensityon RA-treated cells (Fig .66
￿
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TABLE IV
RA Enhancement of Leu-17 Expression on B Cell Hybridomas
Cells were cultured for 3 d in the absence or presence of 10-6 M RA. Initial cell density
was 5 x 104 cell/ml . Staining and analyses were performed as described in Materials and
Methods.
' WIL2/729 HF is the parental fusion partner for producing the hybridomas. 729-PBL is de-
rived from a normal donor while IE 25.0 is a hybridoma from an IgA-deficiency patient.
The other hybridoma lines are all derived from patients with CVI.
8). Unlike the changes in Ig production which appeared restricted to the CVI hy-
bridomas, Leu-17 inductionby RAoccurred on allhybridomalines tested, although
not ontheparent line WIL2/729 HF (Table IV). Changes in Leu-17 expression were
rapid; significant differences were detectable by 8 h, but the maximal stimulation
was present only after 72 h (Fig. 8). There was no consistent change induced by
RA in the other surface markers shown in Table III.
ReversibilityofRA-induced Changes.
￿
To test for the reversibility ofthe RA-induced
effects on CVIhybridomas, weassessed Leu-17 expression andIgM production after
the exposure ofjK 32.1 cells to RA and subsequent withdrawal ofthe drug. Control
or RA-treated (10-6 M) cells were initially cultured for 72 h, washed three times,
then recultured with or without RA at a concentration of 2 x 105 cell/ml. Every
3-4 d, supernatants were assessed forIgM production, cells were stained for Leu-17
TABLE V
Reversibility ofRA-induced Changes in JK 32.1 Cells
' Cumulative concentration in culture supernatant from 3 d before to the day indicated.
Cells were cultured in 10-6 M RA for 3 d, washed, then recultured without RA.
S Cells were cultured continuously in the presence of 10-6 M RA.
B Not tested.
Cell line"
Control cultures
Percent Mean Peak
positive channel channel
RA-treated cultures
Percent Mean Peak
positive channel channel
WIL2/729 HF 18 71 45 22 75 42
729-PBL 14 79 45 89 136 154
IE 25.0 52 95 42 96 192 227
RB 18.C7 22 78 44 93 122 146
FG 7.0 43 84 48 97 134 135
FG 3.1 15 69 41 48 85 45
JL 6.4 31 96 45 92 116 122
JK 32.1 18 91 53 98 177 195
LB B9 45 88 44 91 126 129
Days in
culture
Leu-17
Untreated
(percent
RAI:
positive)
RA2S Untreated
IgM'
RA11 RA2S
ng/mt
0 19 18 20 NT11 NT NT
3 16 97 97 24 280 280
7 18 98 97 26 263 282
14 31 58 93 26 144 571
17 24 39 98 9 16 457SHERR ET AL.
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TA9t.E VI
Induction of IgM Synthesis from Fresh B Cells of Patients with CVI
Small resting B cells from heparinized venous blood were isolated by unit gravity sedimen-
tation (27). The cells were then stimulated for 7 d as indicated and the IgM in the culture
supernatants was quantitated by isotype-specific ELISA. RA was used in 10-6 M, SAC was
used at 0.001 %, and TRF at 10% vol/vol. Results with the normal shown are representa-
tive of that obtained with cells from a total of five normal donors.
Not tested.
expression, and the cells were recultured at the original concentration. As seen in
Table V after the initial 3-d treatment with RA, there was an 11-fold increase in
supernatant IgM concentration over concurrent controls and an increase in Leu-17
expression from <20 to 98%. By 17 d, those cells that had been cultured constantly
with RA had a 50-fold increase in their 14-17-d supernatant concentration ofIgM
over controls. In those cultures RA-treated for the initial 3 d only and then recul-
tured without RA, IgM secretion and Leu-17 expression remained elevated for >2
wk but eventually returned to prestimulated levels after 17-21 d.
Elects ofRA on IgM Secretionfrom Fresh B Cellsfom CVI Patients.
￿
In light ofthe
demonstrated effects of RA on CVI hybridoma B cells, we have undertaken initial
experiments to determine the effects ofRA on fresh B cells obtained from CVI pa-
tients. Inprevious studieswe have shown thattheselymphocytescannot beactivated
by TRF to produce antibody, but that Ig secretion can often be induced by com-
bining TRF with SAC (30). As seen in Table VI, RA treatment ofB cells from two
offourCVI patients enhanced IgM secretionthree tosixfold inresponse toTRF/SAC.
Incontrast, B cellsfrom normal donors did not show similar effects induced by RA.
This enhancing effect by RA with the fresh B lymphocytes from the two patients
(Nos. 113 and 115) are analogous to the RA responsiveness ofthe CVI hybridomas
constructed with cells from these same patients UK 32.1 andJL 6.4, respectively).
We do not have hybridoma lines derived from lymphocytes ofpatients 111 and 125.
Although presentlylimited in scope, these initial experiments suggestthat informa-
tion gained on the ability ofRAto modulate the maturation ofthe CVI hybridomas
will be relevant also towards understanding the biology of this compound on fresh
CVI B cells.
Discussion
This report demonstrates that RA induces the differentiation of human-human
B cell hybridomas from individuals with CVI. These CVI hybridomas reflect the
B cell defect ofthefusion partnerasindicatedbylowlevels ofIgM secretion, imma-
Stimulus
Patient
115
Patient
113
IgM produced
Patient
125
Patient
111 Normal
nglml
None 0 0 0 0 0
SAC 9 0 NT' NT 60
SAC + RA 41 12 NT NT 30
TRF 0 2 0 0 100
SAC + TRF 122 8 26 18 110
SAC + TRF + RA 380 49 22 8 11068
￿
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ture surface markers, and RNA processing resulting in preferential production of
gm vs. gs mRNA. The result ofRA treatment was a marked enhancement in the
secretion ofIgM percell. This enhancement was notcoupled to RA-induced altera-
tion in the cell cycle and was seen with all ofthe CVI hybridomas but not with hy-
bridomas from cells of normal individuals or those with selective IgA deficiency.
In addition toenhancingIgsecretion, RA increased the de noao synthesis ofthelight
and heavy Ig peptides (up to 4- and 15-fold, respectively). RA did not appear to
affect the rate of secretion relative to synthesis since the percent oflabeled Ig that
wasfoundin the supernatant versus thecelllysate was not altered (unpublished data).
Ourresultssuggest that RA treatment ofacell bearingthe CVI phenotype affects
twoaspects ofIg gene expression. First, thesteady-state levels ofthe heavyand light
chain mRNAs are increased. This increase is unlikely to result from an increased
transcription rate since this parameter appearsto be relatively invarient amongcells
representing veryearlyandverylate B lymphoid stages (31). Hence, RA may exert
its effect on a little understood post-transcriptional mechanism which leads to an
accumulation ofIgmRNAinRA-treated cells. Secondly, the processing ofthe heavy
chain transcript to the secreted form is favored over the membrane form after RA
treatment. This shift hasbeen observed in the murine line 70Z/3 (29) andin freshly
isolated murine B cells after stimulation by anti-g and TRF (32). Our results dem-
onstrate the first observed shift ofthis nature in human cells. Although the mecha-
nism used by the cell to discriminate between the two RNA processing pathways
is not understood at this time, the results confirm that RA affects a marked altera-
tion in the differentiated state of the CVI hybridoma clones.
The differentiation effects ofRA on the CVI hybridomas are further supported
byourfindingthatRA substantially increasedthe surfaceexpressionofLeu-17 (CD38),
amarker that reappears late inB cell development on pre-plasmacells (33). Similar
to de noao Ig proteinsyntheses, increased Leu-17 expression was observable after only
8 h culture with RA. Both Leu-17 expression and IgM secretion remained elevated
for long periods (>2 wk) after removal of RA. This finding is consistent with the
long-term effects ofRA in other cell systemswhere differentiation is induced (2-4),
as opposed to the rapidly reversible growth inhibition (<48 h) that can be caused
by RA in the absence ofdifferentiation (1, 5). The mechanism ofthe slow reappear-
ance ofthe pre-RA treatment phenotype of the CVI hybridomas is not known. It
is possible thatall thecells gradually return totheless differentiated state or, alterna-
tively, that a small subset of RA-nonresponsive cells eventually regrow in the cul-
tures. This latter possibility appearsunlikely since afterremoving RAfrom the cul-
ture, both treated and untreated cells had comparable rates of DNA synthesis
(unpublished observation), suggesting no obvious growth advantage forless differen-
tiated cells. Studies using cloned populations ofRA-responsive and nonresponsive
cells will directly address this question.
Animportantissuewhen evaluating thedataherein iswhether theRA-responsive
phenotypeoftheCVI hybridomas isderived from theCVIB cellsor from theparent
line. The evidence we have accumulated suggests that the changes reflect alterations
in the development program ofthe CVI lymphocytes: (a) RA had no effect on pa-
rental WIL2/729 HF cells; (b) enhancement of IgM secretion was seen only with
the CVI hybridomas and not with those constructed with cells from normal or IgA
deficiency patients; (c) we observed similar RA enhancement ofIg secretion fromSHERR ET AL.
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fresh peripheral B cells of two offour CVI patients but not from those of normal
donors. In contrast, RA markedly enhanced Ig secretion fromnormal tonsil B lym-
phocytes (9, and unpublished data), cells that areknown to show substantial differ-
ences in their maturational profile from their peripheral counterparts (34). Thus,
the ability ofB lymphocytes to be affected by RA might be dependent on the pres-
ence ofcellsin a certainstageofdevelopmentthat areoverrepresentedintheperiph-
eral blood ofCVI patients due to the apparent maturational block associated with
the disease. If such is the case, it is possible that RA or other retinoids may play
a role in alleviating this syndrome.
Summary
Human-human B cell hybridomas constructed from B lymphocytes ofcommon
variable immunodeficiency(CVI) patients andthe nonsecreting celllineWIL2/729
HF consistently secrete low levels ofIg and appear to retain a defect characteristic
ofthe CVI patient's B cells. We assessed the differentiative capacity ofretinoic acid
(RA) on these hybridomas, as well as on hybridomas constructed from normal B
cells and from patients with selective IgA deficiency. RA at concentrations varying
between 10-5 and 10-s Maugmented IgM secretion 4-20-fold from four offour CVI
hybridomas tested, but did not affect Ig secretion from normal or IgA-deficiency
hybridomas. In support ofthis elevated Ig secretion, RA enhanced the de novo syn-
thesis of biosynthetically labeled light (x) and heavy (p) Ig (up to 4- and 15-fold,
respectively) inthe CVIhybridoma lineJK32.1. Theincrease in IgMsynthesis/secre-
tion could not be accounted for by RA-induced alteration in the cell cycle. In in-
ducing this increase in IgM production, RA was found to affect two aspects of Ig
gene expression: (a) the steady-state levels ofheavy and light chain mRNAs were
enhanced, and (b) the processing ofp heavy chain transcripts to the secreted mRNA
form became favored over the membrane mRNA form. We also show that expres-
sion ofLeu-17 (CD38), a surface marker that is re-expressed in the late pre-plasma
stage ofB cell development, was increased by RA from <201 Io to >90% ofthe total
cell population, with a concomitant 4-10-fold augmentation in the mean fluores-
cence intensity. Changes in both Leu-17 expression and de novo Ig synthesis were
prominent by 24 h, but could be observed as early as 8 h after induction. Taken
together, our studydemonstrates that RAaffects a markedalteration in thedifferen-
tiated state of the CVI hybridoma clones. This finding suggests that retinoids can
enhance the functionalcapabilities ofB cellswith defects in maturation and support
further studies to evaluate their clinical potential in CVI.
We wishto thank Dr. P Leder for the human x clone pHuKgpt', and Dr. W. Salser forthe
human R-actinclone pHL1216. Wewouldalsoliketo thank Aimee Nguyen andAlexis Brown
fortheir technical assistance, Ingrid Schmid for performingthecell-cycle analysis, andKathy
Petersilie for the flow cytometric studies.
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